Wellcome Leap

Supports developing tools and models to improve executive function outcomes in children during the first thousand days.

Supports research reducing women's Alzheimer's risk through endocrinology-based biomarker and imaging discovery.

Funds tissue profiling platforms enabling early disease detection and clinical intervention.

Helps Dynamic Resilience to support identify validate causal biomarkers of health resilience enable reduction frailty progression.

Helps Focused Antibiotics for spare the gut microbiome without losing treatment efficacy.

Helps FORM for Decode the maternal and infant gut microbiomes role in infant immune and metabolic outcomes.

Helps HOPE for advance drug testing and improve renal disease outcomes.

Funds In Utero to support cut stillbirth rates half developing scalable non-invasive methods measure predict gestational development.

Funds integrated biological approaches for anhedonic depression through multidisciplinary teams that combine clinical and molecular insights.

Helps The Missed Vital Sign for Reduce the time a woman experiences heavy menstrual bleeding from years to months.

Runs a United Kingdom-linked program connecting quantum hardware and life-science teams to tackle hard biological problems.

Helps Global for continuous-flow RNA medicine manufacturing at scale for innovation and strategic advancement.

Helps SAVE for global surgical provider training that increases access and reduces postoperative deaths through practical pathways.

Supports developing predictive risk tools and novel interventions for substance use disorder prevention and treatment.

Helps VISIBLE for Advance diagnosis and treatment of coronary microvascular disease in women from under to over.